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Abstract
Background: The lack of development of local donor tissue acquisition in several regions of the world has resulted
in the necessity of performing keratoplasty with imported donor corneas. The greatest concern about the use of
donor corneas supplied by foreign eye banks is the effect of the increased donor death-to-operation time which
inevitably occurs during the tissue recovery, tissue processing, and tissue transfer between the countries. The purpose
of this study was to report the outcomes of descemet stripping automated endothelial keratoplasty (DSAEK) using
imported donor corneas.
Methods: This retrospective, non-comparative case series investigated the outcomes of the 102 consecutive DSAEK
procedures using imported donor corneas performed at a single university-based hospital between August 2006–2014.
The main outcome measures were postoperative best-corrected visual acuity (BCVA), endothelial cell density (ECD), and
complications.
Results: The mean death-to-operation time was 9.52 ± 1.48 days (range, 8–13). The mean preoperative ECD was
2761 ± 285 cells/mm2. Fuchs’ endothelial dystrophy was the predominant indication for grafting. The mean follow-up
duration was 65.3 months. Ninety-three eyes had improved vision postoperatively (91.18%). BCVA unchanged in 3 eyes
due to preexisting macular scar and advanced glaucoma. Primary graft failure occurred in 6 eyes (5.88%). Of the 93 eyes
with improved BCVA, 100% had their best corrected vision within the first 1 year. The mean ECD at 6, 12, 24, 36, and
60 months after surgery was 1762 ± 294 cells/mm2, 1681 ± 284 cells/mm2, 1579 ± 209 cells/mm2, 1389 ± 273 cells/mm2,
and 1251 ± 264 cells/mm2 respectively. The mean ECD loss at 6 months, 1 year, 2 years, 3 years, and 5 years after surgery
was 36.2%, 39.1%, 42.8%, 49.7%, and 54.7% respectively. The most common complication was graft detachment/
dislocation (10.78%). There were no cases of any postoperative infection.
Conclusions: DSAEK with imported donor corneas provides rapid and good visual rehabilitation. The percentages of
endothelial cell loss were comparable to those achieved in Western series using domestic corneas in which fresher
tissues were available for transplantation.
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Background
Descemet stripping automated endothelial keratoplasty
(DSAEK) has become the first-choice and most popular
method for the treatment of corneal endothelial diseases.
DSAEK appears to be superior to penetrating keratoplasty
(PK) in terms of rapid visual recovery and refractive stabil-
ity, surgically induced astigmatism, higher order aberra-
tions, structural strength of the eye, postoperative surface
keratopathy, wound and suture-related complications,
rates of transplant rejection, and intraoperative and late
choroidal hemorrhage risk [1, 2]. However, graft survival
remains an important issue [1, 3]. Most previous studies
found that 1- and 2-year endothelial cell losses were
greater following DSAEK, consistent with more donor tis-
sue manipulation in DSAEK [2–7]. Fortunately, the graft
success rate and endothelial cell loss in the surviving grafts
were comparable at 3 and 5 years for DSAEK and PK pro-
cedures [8, 9]. Nonetheless, acceleration of cell loss may
lead to earlier onset of late endothelial failure and ultimate
graft decompensation [1].
The shortage of donor corneas is a major issue world-
wide. Many countries, including Thailand, face this
problem as cornea donation is not allowed or encour-
aged in some cultures due to the religious faith and trad-
itional beliefs. To overcome the insufficient donor
supply, we have been using both donor corneas from
oversea eye banks and domestic donor corneas for
keratoplasty. Excellent efficacy and safety of PK utilizing
foreign donor corneas have been previously demon-
strated [10–12]. Also, there has recently been a report
showing the satisfactory outcomes of DSAEK performed
with internationally shipped, precut donor corneas [13].
The study was conducted in Japan and the approximate
flight duration time from the United States to Narita
plus the overland freight transportation time was only
17–18 h. However, the flight between the United States
and Bangkok and the overland transit takes about 48 h.
This raises additional critical concerns regarding the
suitability of foreign donor corneas for the Thai popula-
tion, corneal graft survival associated with imported
tissue, the potential loss of endothelial cell density
(ECD) and viability secondary to prolonged donor
death-to-operation time, and unexpected consequences
caused by the transportation over longer distances such
as tissue damage or the growth of infectious organisms.
The purpose of this study was to assess the efficacy and




This was a single-center, retrospective, non-comparative
interventional case series, analyzing the outcomes of
DSAEK using imported donor corneas in patients with
corneal decompensation due to endothelial failure.
Clinical data were obtained from a review of the medical
records.
Participants
One hundred and two eyes of 95 patients with endothe-
lial decompensation who underwent DSAEK at Ramathi-
bodi Hospital, Bangkok, Thailand, from August 2006
and August 2014, with a minimum follow-up of
24 months were recruited into this trial. Patients with
the accompanying risks of anterior segment abnormal-
ities or further surgeries unrelated to the DSAEK
procedure that may influence postoperative endothelial
cell survival were excluded from the study. The study
was approved by the ethics committee of Mahidol
University School of Medicine and adhered to the tenets
of the Declaration of Helsinki. All patients were in-
formed regarding the advantages, disadvantages, and po-
tential complications of this surgery and emphasized the
importance of postoperative care and need for regular
follow-up and monitoring after surgery. Written in-
formed consent was obtained from each individual prior
to enrollment in this study.
Interventions
All donor corneas were provided by Eye Bank Associ-
ation of America (EBAA)-accredited facilities in the
United States. Each tissue met EBAA minimum stan-
dards of donor age, ECD, and death-to-preservation
time. The corneas were transported as corneoscleral but-
tons housed within corneal viewing chambers filled with
Optisol-GS (Bausch & Lomb, Rochester, NY). The view-
ing chambers were sealed with plastic wrap, packed in a
plastic bag, and positioned in a soft foam block to pre-
vent excessive movement. The foam blocks were again
sealed in a plastic bag and placed into generic, thick-
walled, expanded polystyrene foam shipping containers
with wet ice. The packages were sent from the United
States to Bangkok Suvarnabhumi International Airport
and then transferred to Ramathibodi Hospital via FedEx.
The containers were maintained at 2 °C–8 °C in
validated shipping containers throughout the entire
shipment process. Upon arrival at Ramathibodi Hospital,
a technician collected the container and completed a tis-
sue arrival check, including the date and time of arrival,
condition of the shipping container, number and status
of the ice blocks, number of donor tissues, and status of
each viewing chamber. Also, the technician matched and
confirmed the documentation accompanying each tissue,
and delivered it to the operative room (OR) charge
nurse. The tissue and its package must have been
received in good condition otherwise it would have been
considered not suitable for transplantation. The OR
charge nurse placed it in the temperature-controlled
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refrigerator. On the day of surgery, the tissue was
removed from the refrigerator, reevaluated whether it was
well suited for transplantation, and allowed to warm to
room temperature in the operating theatre for 30–60 min
prior to use.
Two novice surgeons (KL, VC) performed the DSAEK
procedures under either local or general anesthesia. The
donor tissue was dissected with a microkeratome in all
cases using the Moria ALTK system (Moria Surgical,
Antony, France). Tissue preparation was done by the
operating surgeon in 33 eyes and by an US eye bank
technician (pre-cut tissue) in 69 eyes. Descemet’s mem-
brane and diseased endothelium were stripped from the
planned graft area using the reverse Sinskey hook and a
DSAEK stripper. Venting incisions were made to im-
prove graft adherence. A 4.5–5 mm clear corneal inci-
sion was created using a 3.0 mm—wide slit knife for
graft insertion. The donor cornea was cut to a diameter
of 7.5–9.0 mm, depending on the recipient corneal
diameter. The trephined donor posterior lenticule was
inserted into the recipient anterior chamber using Busin
glide (Moria, Doylestown, PA). Once the donor graft
was properly unfolded and well centered, it was pressed
up against the recipient stroma with air. After the anter-
ior chamber was filled completely with air for 10 min,
the air bubble was then reduced to prevent pupillary
block. Beginning with case 9, the inferior peripheral iri-
dectomy was performed prior to donor insertion to
allow leaving nearly a full air fill in the anterior chamber
at the end of surgery without producing pupillary block.
Postoperatively, each patient received topical cortico-
steroids (1% prednisolone acetate) 8 times daily and an-
tibiotics 4 times daily for the first 2 weeks. They were
gradually tapered at the discretion of the operating sur-
geons to 1 drop per day dosing, continued indefinitely.
Steroid responders received intraocular pressure (IOP)-
lowering medications. Also, prednisolone acetate 1% was
changed to fluorometholone as needed. Patients were
examined daily until the residual air bubble did not
cover the pupil when the patient sat up and corneal re-
epithelialization was complete and then discharged from
the hospital. Follow-up evaluations were performed at
0.5, 1, 3, 6, 9, and 12 months after surgery and then
every 6 months thereafter.
Outcome measures
The primary outcome measures included postoperative
best-corrected visual acuity (BCVA), endothelial cell
density (ECD), and complications. The secondary out-
come was the relationships of the postoperative ECD
with donor age, death-to-preservation time, death-to-
operation time, and baseline donor ECD. Preoperative
donor ECD was evaluated by provider eye banks in the
United States using specular microscopy. Postoperative
ECD was determined by noncontact specular micros-
copy (EM-3000; Tomey, Nagoya, Japan) in our clinic at
6 months, 1, 2, 3, and 5 years after surgery. The central
corneal endothelium was photographed using the auto-
alignment and auto-shot functions of the instrument.
The best-quality image is automatically selected and an-
alyzed by the preinstalled software of the instrument
(Cell and Layer Analyser; Tomey). The number of ana-
lyzed corneal endothelial cells and cell density were
automatically calculated using the fixed-frame counting
method in an area set to 100 μm2 without manual cell
border correction. At least 50–100 cells were required to
be examined for each image and the postoperative ECD
was recorded. Percentage of endothelial cell loss was
calculated by subtracting postoperative ECD from pre-
operative ECD and dividing by preoperative ECD, and
then multiplying by 100. Endothelial polymorphism and
polymegathism analyses were not performed. Anterior
segment OCT was also not performed postoperatively as
a result of the unavailability of the equipment at that
time. Patients having complications received intensive
care in collaboration with other subspecialists.
Statistical analysis
Statistical analyses were performed with the statistical
software package STATA version 11.1 (Stata Corp,
College Station, Texas, USA). Continuous data were
expressed as either mean ± standard deviation (SD) or
median and range, depending on the normality of distri-
bution. These were compared using independent t test
or Mann–Whitney U test respectively. Categorical data
described as frequency and percentage, were analyzed
with Chi-square or Fisher’s exact tests. Associations
between postoperative ECD at 5 years and various donor
or recipient characteristics were evaluated using linear
regression analysis. Multiple regression analysis was
performed for only variables that were statistically sig-
nificant by univariate analysis. P-values less than 0.05
were considered to be statistically significant.
Results
Donor characteristic data including donor age, death-to-
preservation time, death-to-surgery time, residual stromal
bed thickness after microkeratome cutting, and ECD are
summarized in Table 1. Data were not available on all pa-
rameters for all donor tissues due to either no information
provided from the Eye Banks or missing data. Death-to-
operation time was greater than or equal to 8 days in all
corneas. An 8.0- to 8.5-mm donor disc was used in
94.12% of cases. Table 2 presents patient demographics
and indication for surgery. The mean recipient age was
64.21 ± 19.56 years, 58.82% were female, and fuchs’ endo-
thelial dystrophy and pseudophakic bullous keratopathy
(PBK) were the predominant indications for grafting.
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Forty-two DSAEK operations (41.18%) were performed in
combination with phacoemulsification and posterior
chamber intraocular lens implantation (IOL). Most
patients had no preexisting glaucoma. Only 6 patients had
undergone prior glaucoma surgeries. The mean follow-up
duration was 65.3 months (range, 24 to 96 months).
Overall, BCVA in 102 eyes at 6 months improved to
20/63 (range 20/20 to 20/200), representing an average
gain of 5 Snellen lines from preoperative vision
(P < 0.01). Preoperative BCVA was ≤20/200 in 80 eyes
(78.43%) and ≤20/40 in 101 eyes (99.02%). Ninety-three
eyes had improved vision postoperatively (91.18%).
BCVA unchanged in 3 eyes (2.94%) due to preexisting
macular scar (2) and advanced glaucoma (1). Six eyes
(5.88%) experienced a decline in vision secondary to pri-
mary graft failure. Of the 93 eyes with improved BCVA,
100% had their best corrected vision within the first 1 year.
Postoperatively, 9.80% achieved a BCVA of ≥20/25,
50.98% achieved ≥20/40, and 79.41% achieved ≥20/100 by
the last follow-up (Fig. 1).
The mean preoperative ECD was 2761 ± 285 cells/mm2
(range, 2361–3015). Among eyes examined with clear
grafts, the mean ECD at 6, 12, 24, 36, and 60 months after
surgery was 1762 ± 294 cells/mm2, 1681 ± 284 cells/mm2,
1579 ± 209 cells/mm2, 1389 ± 273 cells/mm2, and
1251 ± 264 cells/mm2 respectively. The mean ECD loss
at 6 months, 1 year, 2 years, 3 years, and 5 years after
surgery was 36.2%, 39.1%, 42.8%, 49.7%, and 54.7%
respectively (Table 3). From univaraite and multivariate
analyses, 5-year ECD was not significantly correlated
with donor age, death-to-preservation time, death-to-
surgery time, and graft diameter. The baseline donor
ECD was the only variable positively significantly
associated with 5-year ECD (P = 0.02).
Postoperative complications after DSAEK surgery are
shown in Table 4. The most common complication was
graft detachment (11 eyes, 10.78%). Three eyes experi-
enced donor lenticule dislocation into the anterior
chamber on the first postoperative day and required a
second surgery of graft repositioning and air bubble re-
placement. One of these 3 eyes had had an eccentric
mis-cut with the donor trephine due to a large graft size
(9.0 mm) used and an erroneous reliance by the surgeon
on the center of the donor cornea after precutting the
tissue in the eye bank. The 1.5-mm maximum width and
4-clock hour meridian full-thickness edge was not
trimmed before insertion to avoid the potential endothe-
lial cell insufficiency and attendant excessive endothelial
trauma. This patient suffered recurrent dislocation on
the second postoperative day and needed a second repo-
sitioning and rebubbling of the graft for it to become
attached. Despite the successful graft reattachment, the
graft remained edematous and was considered iatrogenic
donor failure. The patient refused to have a repeat
Table 1 Donor Characteristics of 102 imported donor corneas
for Descemet stripping automated endothelial keratoplasty
Characteristics Number
Mean age (year) 63.85 ± 15.94
(range, 20–75)
Death-to-preservation time (hours) 12.52 ± 7.45
(range, 5–20.45)
Death-to-operation time (days) 9.52 ± 1.48 days
(range, 8–13)
Endothelial cell density (before precut) (cell/mm2) 2761 ± 392
(range, 2361–3015)
Central corneal thickness (μm) 585.53 ± 87.81
(range, 534–685)
(n = 85)
Graft thickness (post-cut) (μm) 142.37 ± 65.29
(range, 96–225)
(n = 65)
Graft diameter, number (%)
- 7.5 mm 3 (2.94)
- 8.0 mm 47 (46.08)
- 8.5 mm 49 (48.04)
- 9.0 mm 3 (2.94)
Table 2 Recipient Characteristics of 102 eyes undergoing
Descemet stripping automated endothelial keratoplasty
Characteristics Number
Mean age (year) 64.21 ± 19.56
(range, 5–90)
Sex Female 60 (58.82%)
Male 42 (41.18%)
Diagnosis, number of eyes (%)
- Fuchs’ endothelial dystrophy 46(45.10)
- Pseudophakic bullous keratopathy 32 (31.37)
- Laser iridotomy induced corneal
decompensation
15(14.71)
- Iridocorneal endothelial (ICE) syndrome 3 (2.94)
-Cytomegalovirus (CMV) endotheliitis 3 (2.94)
- Congenital hereditary endothelial dystrophy
(CHED)
2 (2.78)
- Unknown cause 1 (1.39)
Preoperative lens status, number of eyes (%)
- Pseudophakic 57 (55.88)
- Phakic 45 (44.12)
Combined procedure, number of eyes (%)
- Phacoemulsification with intraocular lens
implantation
42 (41.18)
Glaucoma status, number of eyes (%)
- No preexisting glaucoma 76 (74.51)
- Medically controlled without prior surgery 20 (19.61)
- Prior glaucoma surgery 6 (5.88)
Lekhanont et al. BMC Ophthalmology  (2017) 17:41 Page 4 of 8
DSAEK because of extremely old age and difficulty in
postoperative patient positioning so that she underwent
a new PK. The other 2 eyes were 1 post-trabeculectomy
and 1 post-PK eyes which were unable to maintain air in
the anterior chamber because the air was misdirected
into the bleb in post-trabeculectomy eye and absorbed
too soon in the post-PK eye. After the first graft
repositioning, the grafts were adherent and clear during
follow-up visits in these 2 eyes. The remaining 8 eyes
with graft detachment were successfully reattached with
a rebubble procedure on the next day in a minor
surgical suite.
Primary graft failure occurred in 6 eyes and one of
them was the eye with eccentric mis-cut. Two eyes
required reinsertion of the donor lenticule into the
anterior chamber. Two eyes had a thin, precut donor
lenticule, causing more tissue manipulation during
transfer to the glide. Another eye underwent uneventful
DSAEK using an eye bank-prepared precut cornea. Of
the 6 eyes with primary graft failure, the donor grafts
were surgeon-prepared in 4 eyes and technician-
prepared in 2 eyes. Five patients developed episodes of
endothelial graft rejection and all were treated with
systemic and topical corticosteroids. Graft rejection was
observed within 1 year post-surgery in 2 eyes and after
1 year in 3 eyes. Six eyes experienced late graft failure;
2 was post-rejection, 1 was post-additional IOL surgery,
and 3 had no obvious precipitating factor. Pupillary
block occurred in 6 eyes without surgical peripheral iri-
dectomy at the time of DSAEK. It was relieved by par-
tial removal of the air bubble or peripheral iridectomy.
There was no pupillary block occurred in any cases
after inferior peripheral iridectomy was adopted as a
routine policy. One eye having a diagnosis of PBK sec-
ondary to complicated phacoemulsification with poster-
ior capsular tear experienced posterior IOL dislocation
after DSAEK. It possibly resulted from unrecognized
small zonular dialysis or undetected placement of a
haptic in the capsular bag. The IOL was successfully
repositioned by a retinal specialist; however, the graft
eventually failed 13 months following IOL surgery.
Corneoscleral rim cultures were obtained in all cases
and none had a positive donor rim culture. There were
no cases of infectious keratitis or endophthalmitis.
Fig. 1 Preoperative and postoperative best-corrected visual acuity of 102 patients undergoing descemet stripping automated endothelial keratoplasty
with imported donor corneas
Table 3 Postoperative endothelial cell density and cell loss after
Descemet stripping automated endothelial keratoplasty








Baseline 2761 ± 285
(2361–3015)
102
6 months 1762 ± 294
(1084–2263)
96 36.2 (±13.9)
1 year 1681 ± 284
(997–2115)
92 39.1 (±12.4)
2 years 1579 ± 209
(753–2048)
85 42.8 (±13.1)
3 years 1389 ± 273
(729–1893)
79 49.7 (±14.7)
5 years 1251 ± 264
(683–1589)
72 54.7 (±13.9)
Table 4 Postoperative complications after Descemet stripping
automated endothelial keratoplasty
Complications Number of eyes (%)
Graft dislocation/detachment 11 (10.78)
Primary graft failure 6 (5.88)
Pupillary block 6 (5.88)
Late graft failure 6 (5.88)
Graft rejection 5 (4.90)
Secondary angle closure glaucoma 3 (2.94)
Intraocular lens dislocation 1 (1.39)
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Discussion
The lack of development of local donor tissue acquisi-
tion in several regions of the world has resulted in the
necessity of performing DSAEK with internationally
shipped donor corneas. The greatest concern about the
use of donor corneas supplied by foreign eye banks is
the effect of the increased donor death-to-operation
time which inevitably occurs during the tissue recovery,
tissue processing, and tissue transfer between the coun-
tries. In addition, the shipping-related vibration effects
and the changes in the air pressure caused by air
transport might affect the quality of the donor corneas
[13, 14]. Thus, outcomes of DSAEK using imported
donor corneas with longer-distance transportation have
yet to be determined.
Our study demonstrated that despite having longer
transportation time, there was a satisfactory BCVA
improvement in 91.18% of patients after DSAEK using
imported donor corneas. Additionally, although the
postoperative mean ECD at 6 month, 1, 2, 3, and 5 years
of this study was lower than those of the Japanese report
and previous studies of domestically shipped corneas,
the percentage of endothelial cell loss at each time point
in our study was similar to those of such studies [6–8, 13].
Since the mean preoperative ECD before precutting and
the percentage of postoperative endothelial loss in this
study were not obviously different from those of previous
studies, the lesser postoperative mean ECD at all follow-
up time points might be due to the lower number of ECD
just prior to surgery. However, this could not be con-
firmed because the eye bank specular microscope was
unavailable at our institute so that changes in the ECD
secondary to precutting process and overseas transporta-
tion were not assessed. Although there is no considerable
loss of donor endothelial cells during the first week of
storage in Optisol media [13, 14], the ECD would be
expected to decrease steadily and probably drop below the
level of 2200 cells/mm2 after the 10th post-harvest day
[15]. In this study, death-to-operation time was greater
than or equal to 8 days in all corneas. Thus, re-evaluating
tissue stored in Optisol-GS for more than 7 days by repeat
specular microscopy prior to using the tissue may be
recommended if the equipment is provided.
With respect to the relationship between donor tissue
storage time and the probability of endothelial survival,
there has still been conflicting evidence in the literature.
A significant correlation between prolonged storage time
(> 7 days) and increased risk of graft failure has been
reported in PK with imported donor corneas [16].
Nevertheless, this outcome might be caused by the use
of tissues for high-risk PK. Recent studies showed the
opposite finding that in a series of low-risk PK, there
was no correlation between preservation-to-surgery time
and graft survival probability [10, 17]. As for DSAEK,
previous studies from Japan found that there was a
statistically significant decrease in ECD (2.3–3.79%)
associated with overseas transportation of corneal grafts,
however, all graft had an ECD before surgery of greater
than 2000 cells/mm2 and were available for DSAEK
[13, 14]. The clinical outcomes of DSAEK with
internationally shipped precut donor corneas were also
acceptable and that the endothelial cell loss caused by
transportation did not appear to influence the clinical
results [13]. No association between the storage time
and the decline in ECD was observed as well [14, 18].
Furthermore, a wide range of values for the precut
donor characteristics such as donor age, death-to-
transplantation time, precutting-to-transplantation time,
and donor lenticule thickness resulted in excellent
adhesion of the tissue and clear grafts [19]. Also, none
developed primary graft failure in previous studies
[14, 19]. These findings might be explained by the rela-
tively short death-to-surgery time in all patients in prior
studies. The longest storage time in previous studies either
using internationally (Japanese series) or domestic shipped
precut donor corneas (US series) was not greater than
8 days. Meanwhile, the donor corneas in this current
study had 4.92 extra days of storage time compared to the
Japanese report [13] and the storage time of the shortest
stored corneas was 8 days (range, 8–13). Even though the
overall results were favorable and no significant correl-
ation between death-to-surgery time and 5-year ECD was
seen, there were 6 cases of primary graft failure (5.88%),
11 cases of graft detachment (10.78%), and 3 cases of late
graft failure without precipitating factor (2.94%) in our
series which is higher than those found the Japanese
series. Possible explanations could be both surgical
technique and donor characteristics issues. Since the
authors were not already experienced DSAEK surgeons,
some cases were during our learning curve. The primary
graft failure was more common in the earlier cases and at
least half of these (3 cases) were iatrogenic (one mis-cut
and 2 with more tissue manipulation). This presumably is
unrelated to the shipping and storage time. However, as
the surgeons were past their learning curve plus the surgi-
cal technique used and the rates of endothelial cell loss in
this study are similar to those of other studies, the donor
characteristics of the longer tissue storage time may be
another reason. The baseline donor ECD was also the
variable positively significantly associated with 5-year
ECD. Therefore, despite the fact that postoperative com-
plications in DSAEK are not tissue dependent, but rather
technique dependent; and the higher preoperative endo-
thelial cell counts may not protect against the postopera-
tive event of primary graft failure or graft dislocation, nor
may they ensure a higher postoperative cell count than
tissues with lower cell counts before surgery in corneas
stored in Optisol-GS for ≤7 days [5, 18], using the donor
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corneas with high cell counts along with performing a
flawless surgery may be necessary if a donor tissue for
DSAEK has been stored for more than 7 days. Moreover,
minute surgical trauma might have an over detrimental
effect when using the vulnerably old donor corneas with
low cell counts.
It is interesting that the endothelial cell density was
slightly changed between 36 and 60 months. This corre-
sponds to the earlier finding that long-term endothelial
cell loss in DSAEK patients plateaus more quickly than
in those who undergo PK [7, 8]. The impact of less long-
term postoperative endothelial cell loss after PK with
large donor diameter might be applicable in DSAEK
[20], as grafts larger than 8.0 mm in diameter were com-
monly used in our DSAEK patients. However, the results
were conditional on surviving grafts. The ECD of
patients with graft failure could not been measured and
calculated because of poor quality scans. Hence, there
was the potential bias owing to dropout of eyes from the
analysis data set when grafts failed [20].
Considering the occurrence of other postoperative
complications, graft rejection was found in only 4.9%,
secondary angle closure glaucoma in 2.94%, and no
infectious keratitis or endophthalmitis was seen in this
series. This observation suggests that DSAEK using
foreign donor corneas with prolonged storage time have
a good safety profile, resembling those using domestic
donor corneas [21].
The limitations of this study included the small and
heterogeneous patient populations, 2 different surgical
techniques used (precut and surgeon-cut), short follow-
up time, no comparison of endothelial cell loss between
the early and later cases, and inherent shortcomings in
any retrospective study.
Conclusions
In summary, the outcomes of DSAEK performed with
internationally shipped donor corneas were acceptable
and the percentages of endothelial cell loss were compar-
able to those achieved in Western series using domestic
corneas in which fresher tissues were available for trans-
plantation. This study also supports the efficacy and safety
of imported donor corneal tissues stored greater than
1 week and up to 13 days. Cornea donation from overseas
eye banks may be of substantial benefit to patients in
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